---
{
  slug: "silhouette",
  title: "Silhouette InstaLift",
  subtitle: "FDA-cleared absorbable suspension suture system with bidirectional cone technology",
  division: "aesthetics",
  company: "tiger-aesthetics",
  category: "Thread Lift",
  tech: ["Micro Suspension Technology", "Bidirectional Cone Technology", "PLGA Bioabsorbable Material"],
  indications: [
    "Mid-face suspension and tissue repositioning",
    "Temporary fixation of cheek subdermis in elevated position",
    "Mild to moderate facial sagging and laxity",
    "Nasolabial folds",
    "Marionette lines",
    "Jowls",
    "Facial volume restoration"
  ],
  benefits: [
    "Immediate lifting effect with long-term collagen stimulation",
    "Natural-looking facial rejuvenation results lasting up to 24 months",
    "Minimally invasive in-office procedure completed in under one hour",
    "Minimal downtime of 24-48 hours with reduced recovery versus surgical facelift",
    "No serious adverse events reported in clinical studies of over 500 patients",
    "82% patient satisfaction rate at 3 months post-treatment",
    "Dual-action: immediate lift plus gradual volumizing through collagen production",
    "Biocompatible and fully absorbable material",
    "Less than 5% bruising rate in clinical trials"
  ],
  evidence: [
    {
      title: "Facial Lift and Patient Satisfaction Following Treatment with Absorbable Suspension Sutures: 12-Month Data",
      authors: "Nestor MS, et al.",
      journal: "Journal of Clinical and Aesthetic Dermatology",
      year: "2019",
      citation: "J Clin Aesthet Dermatol. 2019 Mar;12(3):18-26",
      pmid: "30988869",
      link: "https://pmc.ncbi.nlm.nih.gov/articles/PMC6440704/",
      findings: "Prospective controlled study of 20 patients showed 30% achieved ≥1.5mm lift at Week 8, 60% maintained ≥0.5mm lift at 12 months. Mean age perception decreased by 3.4 years. Significant improvements in FACE-Q satisfaction scores with minimal adverse events."
    },
    {
      title: "Straight-Line Vector Planning for Optimal Results With Silhouette InstaLift",
      authors: "Lorenc ZP, Goldberg D, Nestor M",
      journal: "Journal of Drugs in Dermatology",
      year: "2018",
      citation: "J Drugs Dermatol. 2018;17(7):786-793",
      pmid: "30005090",
      link: "https://pubmed.ncbi.nlm.nih.gov/30005090/",
      findings: "Analysis of over 500 patient treatments showed no serious adverse events, less than 5% bruising rate, with repositioning results evident up to 24 months when proper straight-line vector planning technique is used."
    },
    {
      title: "Silhouette Instalift: Benefits to a Facial Plastic Surgery Practice",
      authors: "Archer KA, Garcia RE",
      journal: "Facial Plastic Surgery Clinics of North America",
      year: "2019",
      citation: "Facial Plast Surg Clin North Am. 2019 Aug;27(3):341-353",
      pmid: "31280848",
      link: "https://pubmed.ncbi.nlm.nih.gov/31280848/",
      findings: "Patients characterized InstaLift as immediately effective with improved safety and efficacy profile over predecessor barbed suture thread lifting. Reduced risk of complications and recovery time compared with rhytidectomy."
    }
  ],
  skus: [
    {
      name: "Silhouette InstaLift Suture",
      description: "Absorbable suspension suture with bidirectional cones (variants available with 8, 12, or 16 cones per suture)"
    }
  ],
  regulatory: {
    fda: "FDA 510(k) cleared April 2015 - only FDA-cleared absorbable suture for cosmetic mid-face lifting procedures",
    ce: "EU MDR Class III Certification (marketed as Silhouette Soft in Europe since 2013)",
    510k: "K142061"
  },
  regions: [
    "United States",
    "Europe",
    "Brazil",
    "South Korea",
    "Global distribution through Tiger Aesthetics and international partners"
  ],
  status: "Active",
  downloads: [],
  contacts: {
    sales: "",
    support: ""
  },
  heroImage: "/images/boredoptimism_science_aesthetics_--ar_169_--raw_--profile_e1d_be617358-9084-4f84-b1dc-378a67fd1009_0.png",
  gallery: [],
  seo: {
    title: "Silhouette InstaLift - FDA-Cleared Thread Lift | Tiger BioSciences",
    description: "Silhouette InstaLift is an FDA-cleared, minimally invasive thread lift system using bidirectional cone technology for mid-face lifting and rejuvenation with proven clinical results lasting up to 24 months."
  }
}
---

Silhouette InstaLift is the only FDA-cleared, minimally invasive, absorbable suspension suture system designed to lift and reposition mid-face tissues. Using innovative Micro Suspension Technology with bidirectional cones, this revolutionary treatment provides immediate lifting results while stimulating natural collagen production for long-term facial volume restoration.

## Technology Overview

### Bidirectional Cone Technology

Silhouette InstaLift features a proprietary design comprised of bioabsorbable sutures with strategically positioned bi-directional cones. The sutures are composed of 82% poly-L-lactic acid (PLLA) and 18% poly-lactide-co-glycolide (PLGA), the same proven materials used in other aesthetic treatments like Sculptra.

The bidirectional cone design serves multiple functions:
- **Immediate Suspension**: Hollow cones with large three-dimensional surfaces provide efficient soft-tissue suspension
- **Secure Anchoring**: Cones hold the suture and facial skin in an elevated position
- **Migration Prevention**: The cone geometry reduces risk of suture migration or extrusion
- **Collagen Stimulation**: Over time, the PLGA material stimulates fibroblasts for gradual collagen maturation

### Dual-Action Mechanism

Silhouette InstaLift works through two complementary mechanisms:

1. **Immediate Lifting**: The sutures are placed subdermally to physically elevate and reposition sagging facial tissue, providing instant visible results
2. **Progressive Volumization**: As the bioabsorbable material gradually breaks down over 12-24 months, it stimulates the body's natural collagen production, creating sustained volume and tissue support

## Clinical Evidence

Extensive clinical research has demonstrated the safety and efficacy of Silhouette InstaLift:

### 12-Month Prospective Study
A masked, controlled clinical study published in the Journal of Clinical and Aesthetic Dermatology followed 20 female patients aged 41-75 with moderate facial skin laxity. Using 3D surface imaging and validated patient-reported outcomes:
- 30% of patients achieved ≥1.5mm facial lift at Week 8
- 60% maintained ≥0.5mm lift at the 12-month follow-up
- Mean perceived age decreased by 3.4 years
- Statistically significant improvements in FACE-Q satisfaction scores
- Minimal adverse events with excellent tolerability

### Large-Scale Safety Analysis
Analysis of over 500 patient treatments demonstrated:
- Zero serious adverse events
- Less than 5% incidence of noticeable bruising
- Repositioning results lasting up to 24 months
- Consistent outcomes when proper straight-line vector planning technique is employed

### Patient Satisfaction Data
Clinical studies report impressive patient satisfaction metrics:
- 79% of patients satisfied with results one week post-treatment
- 82% would recommend the treatment to friends or family
- 83% reported continued effectiveness in reducing signs of aging at 3 months

## Treatment Indications

Silhouette InstaLift is FDA-cleared for mid-face suspension surgery to temporarily fixate the cheek subdermis in an elevated position. The treatment is ideally suited for addressing:

- Mild to moderate facial sagging and skin laxity
- Loss of definition in the mid-face area
- Prominent nasolabial folds
- Marionette lines
- Early jowl formation
- Loss of facial volume due to aging
- Mild to moderate descent of cheek fat pads

## Ideal Patient Candidates

### Best Candidates
- **Age Range**: Typically patients in their mid-30s to 50s experiencing early to moderate signs of facial aging
- **Skin Quality**: Individuals with good skin elasticity and adequate underlying facial fat
- **Health Status**: Generally healthy, non-smoking patients with realistic expectations and good healing capacity
- **Facial Characteristics**: Moderate sagging with sufficient but not excessive soft tissue thickness
- **Treatment Goals**: Those seeking natural-looking facial rejuvenation without surgical downtime

### Contraindications
Silhouette InstaLift should not be used in patients with:
- Known allergies or sensitivities to plastic biomaterials
- Very thin facial soft tissue where implants may be visible or palpable
- Very thick or heavy skin
- Active facial infections
- Autoimmune diseases
- Patients under 18 years of age
- Pregnant or breastfeeding women

### Alternative Recommendations
For patients with advanced signs of aging, significant tissue descent, or very thin/thick skin, more robust surgical interventions such as traditional facelift (rhytidectomy) may be more appropriate.

## Procedure Details

### Treatment Time
The entire procedure typically takes under one hour to complete in an office setting, making it highly convenient for busy patients.

### Technique
The procedure involves:
1. Local anesthesia application
2. Small entry points created in the temporal hairline
3. Sutures with bidirectional cones inserted into the subdermal plane
4. Tissue gently lifted and secured in the desired position
5. Straight-line vector planning ensures optimal tissue repositioning

### Recovery
- **Immediate**: Minimal downtime of 24-48 hours
- **Short-term**: Possible mild swelling and bruising that resolves quickly
- **Activity**: Most patients resume normal activities within 1-2 days
- **Results**: Immediate visible lifting with continued improvement as collagen develops

### Duration of Results
Clinical studies demonstrate:
- Immediate lifting effects visible immediately post-procedure
- Optimal results develop over 2-3 months as collagen production increases
- Results typically last 18-24 months
- Some patients report sustained benefits beyond 2 years

## Safety Profile

Silhouette InstaLift has demonstrated an excellent safety profile in clinical studies:

### Minimal Adverse Events
- No serious adverse events reported in clinical trials
- No unanticipated problems or deaths recorded
- Well-tolerated with predictable, manageable side effects

### Common Expected Effects
- Mild swelling (resolves within 24-48 hours)
- Minor bruising (less than 5% of patients experience noticeable bruising)
- Temporary discomfort at insertion sites
- Possible rippling or dimple formation (typically resolves spontaneously)

### Improved Safety vs. Alternatives
Compared to traditional barbed suture thread lifts, Silhouette InstaLift offers:
- Enhanced safety and efficacy profile
- Reduced complication rates
- Lower risk compared to surgical rhytidectomy
- Faster recovery time than facelift surgery

## Regulatory Status

### FDA Clearance
- **510(k) Number**: K142061
- **Clearance Date**: April 2015
- **Distinction**: Only FDA-cleared absorbable suture for cosmetic mid-face lifting procedures
- **Classification**: Minimally invasive, resorbable suspension suture device

### International Approvals
- **Europe**: EU MDR Class III Certification (marketed as Silhouette Soft since 2013)
- **Global**: Available in multiple international markets including Brazil and South Korea

### Clinical Support
Over 1,000 trained providers in the United States have received product and technique education on Silhouette InstaLift, ensuring widespread access to properly trained practitioners.

## Geographic Availability

Silhouette InstaLift has achieved global distribution success:

- **North America**: Direct commercial presence in the United States through Tiger Aesthetics
- **Europe**: Established market presence since 2013 (as Silhouette Soft)
- **Latin America**: Available in Brazil and expanding in the region
- **Asia**: Active markets in South Korea and other territories
- **Distribution**: Tiger Aesthetics Medical, LLC (acquired from Suneva Medical) manages global distribution

## Company Background

Silhouette InstaLift was originally developed by Sinclair Pharma PLC, a global aesthetic company with expertise in advanced dermatological and aesthetic solutions. The product was subsequently acquired by Suneva Medical, and is now part of the Tiger Aesthetics portfolio following Tiger Aesthetics Medical, LLC's acquisition of Suneva and its complete product line, including Bellafill and Amplifine PRP.

Tiger Aesthetics continues to advance the Silhouette InstaLift technology while expanding access through comprehensive provider training and global distribution networks.
